title: Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.
authors.forename: W C
authors.initials: WC
authors.lastname: Chapman
authors.forename: H
authors.initials: H
authors.lastname: Lockstadt
authors.forename: N
authors.initials: N
authors.lastname: Singla
authors.forename: F E
authors.initials: FE
authors.lastname: Kafie
authors.forename: J H
authors.initials: JH
authors.lastname: Lawson
mesh_terms: D000918:Antibody Specificity; D004311:Double-Blind Method; D005781:Gelatin Sponge, Absorbable; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D011994:Recombinant Proteins; D013917:Thrombin / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D007518:Isoantibodies; D011994:Recombinant Proteins; D013917:Thrombin